Generation Bio Newsroom

CCORF Maintains Generation Bio(GBIO.US) With Buy Rating, Maintains Target Price $9

Futu NewsNov 7 22:35

Promising Pipeline and Strong Financials Affirm Buy Rating for Generation Bio

TipRanksNov 7 21:43

TD Cowen Maintains Generation Bio(GBIO.US) With Hold Rating

Futu NewsNov 7 21:31

Needham Maintains Generation Bio(GBIO.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 7 19:31

JMP Securities Maintains Generation Bio(GBIO.US) With Hold Rating

Futu NewsNov 7 14:32

TD Cowen Maintains Generation Bio(GBIO.US) With Hold Rating

Futu NewsNov 7 08:31

Generation Bio Analyst Ratings

BenzingaOct 23 17:45

JMP Securities Maintains Generation Bio(GBIO.US) With Hold Rating

Futu NewsOct 23 13:31

Needham Maintains Generation Bio(GBIO.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 23 02:31

Generation Bio's Promising Advancements and Strategic Collaborations Drive Buy Rating

TipRanksOct 23 01:58

Analysts' Top Healthcare Picks: Generation Bio (GBIO), Bristol-Myers Squibb (BMY)

TipRanksAug 12 08:24

Generation Bio (GBIO) Gets a Hold From JMP Securities

TipRanksAug 9 05:00

Wedbush Remains a Buy on Generation Bio (GBIO)

TipRanksAug 8 22:06

Generation Bio Price Target Maintained With a $5.00/Share by Wedbush

Dow JonesAug 8 21:42

Buy Rating Affirmed for Generation Bio on Strong Financials and Technological Advancements

TipRanksAug 8 21:10

Generation Bio Analyst Ratings

BenzingaAug 8 20:58

Needham Reiterates Buy on Generation Bio, Maintains $10 Price Target

BenzingaAug 8 20:58

Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)

TipRanksMay 23 12:45

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)

TipRanksMay 14 20:55

Wedbush: Reiterates the Generation Bio (GBIO.US) rating and adjusted from superior to superior market rating, with a target price of $5.00.

Zhitong FinanceMay 14 20:32